Chemical Structure (Vivjoa 01)
Vivjoa Capsule
Product Images NDC 74695-823
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vivjoa (NDC 74695-823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mycovia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (150 mg Blister Pack Label)
Dosing directions for VIVIOA™ (oteseconazole capsules), 150 mg per capsule, for oral use. The recommended dosage for the first day is four capsules, and for the second day, it is three capsules. Starting from the third week, take one capsule weekly. The capsules can be removed by pressing from the reverse side. The product is manufactured for Mycovia Pharmaceuticals, Inc. by Patheon and distributed by Mycovia Pharmaceuticals, Inc. Only English characters are available.*
Principal Display Panel (150 mg Capsule Blister Pack Container)
This is a prescription drug with NDC number 74695-82318. The drug is called VIOCEON and contains 150mg of Oteseconazole per capsule. The package insert should be consulted for full prescribing information. The last section appears to be dosage instructions in a foreign language.*
Principal Display Panel (150 mg Capsule Blister Pack Container Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
